Expect Cons to Outweigh Pros for the New CAP Antibiotic Lefamulin (Xenleta)

Lefamulin (Xenleta, zen-LEH-tah) will be the first oral and IV med in a new class of "pleuromutilin" antibiotics.

It's approved for community-acquired pneumonia (CAP) and can be used alone to cover common bugs...Strep pneumo, H. flu, and Mycoplasma.

Lefamulin is not inferior to moxifloxacin for CAP treatment. And lefamulin costs about $200/day for IV...and $280/day for tabs.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals